Effectiveness of dayclinic treatment for adolescents with personality developmental disorders with techniques of the transference focused psychotherapy for adolescents (TFP-A)
- Conditions
- F60-F69Disorders of adult personality and behaviour
- Registration Number
- DRKS00010557
- Lead Sponsor
- niklinik KölnKlinik für Kinder- und Jugendpsychiatrie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 160
For inclusion into the study a written consent form for the study is necessary signed after informed consent (about the procedure of the study as well as their voluntary involvement and the freedom to terminate the participation at any time) by the adolescent who is above 14 years of age or by the parents for patients who are 13 years of age. All patients need to be between 13 to 17 years of age, they have to fulfill at least probable criteria for a personality disorder based on the International Personality Disorder Examination, conducted by a reliable interviewer.
Inclusion criteria for target sample and control sample: Existance of a personality disorder on the Basis of DSM-IV (IPD)
Inclusion criteria for target sample: Treatment in dayclinic.
Inclusion criteria for Waitinggroup: Existence of a personality disorder and written consent to participate.
Exclusion criteria are missing reading knowledge of the German language; an IQ below 70, a disorder from the schizophrenic spectrum; any other disorders of perception, cognition and affectivity which influence neuropsychological testing; a change of medication which influences the CNS during the dayclinic treatment program. Medication which has already been given before inclusion into the program does not fulfill an exclusion criterion.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary Endpoint after 12 weeks of Treatment in the dayclinic. Outcome Parameter: Borderline Symptoms (DAPP; IPO), Aggression and autoaggression (MOAS, FSSV), capability of relationship (IIP). <br>Katamnese after another 3 months
- Secondary Outcome Measures
Name Time Method Secondary Endpouint after another 3 months.<br><br>Secondary Outcome Parameter: Borderline Symptoms (DAPP; IPO), Aggression and autoaggression (MOAS, FSSV), capability of relationship (IIP). <br><br><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.